Cord blood mononuclear cells (CBMCs) are highly valuable in cell therapy and regenerative medicine but also one of the hardest cell types to freeze.Typical workflows lead to low viability, distorted subsets, granulocyte interference, and heavy post-thaw clumping.
A recent customer study shows how CS-PM-D1 overcomes these challengeswith a simple -80°C workflow:
75% post-thaw cell recovery
Far above typical CBMC recovery rates.
Clean immune subsets
Granulocyte interference drops sharply; monocytes remain enriched.
Strong single-cell integrity
Minimal clumping and reliable downstream flow cytometry.
Simple & reproducible workflow
Direct -80°C freezing; no controlled-rate freezer or wash step needed.
Serum-free, low-toxicity formulation with ice-controlling components.
GMP-aligned manufacturing for stable lot-to-lot consistency.
Broad compatibility across immune and stem cell types.
"Thaw & use" design reduces variability and hands-on time.
CBMC research & functional assays.
CAR-T/NK therapy development.
Standardized immune profiling & in vitro pharmacology.
